Showing results (61-70 of 241) with videos related to

Sort By:
Pageof 25
Oncotarget|November 27, 2014
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experienceMing-Mo Hou, Xiaochun Liu, Jennifer Wheler, et al.
Cancer Medicine|November 29, 2021
Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumorsShuyang Yao, Filip Janku, Kimberly Koenig, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2016
Erratum to: Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesSiqing Fu, Kirk S Culotta, Gerald S Falchook, et al.
Cancer Biology & Therapy|August 17, 2012
Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3Siqing Fu, Yanfang Li, Jie Huang, et al.
Investigational New Drugs|December 6, 2013
Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignanciesSiqing Fu, Ming-Mo Hou, Jennifer Wheler, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II studyNazanin Majd, Steven G Waguespack, Filip Janku, et al.
Plos One|June 8, 2012
KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitorsIgnacio Garrido-Laguna, David S Hong, Filip Janku, et al.
Molecular Cancer Therapeutics|May 17, 2011
Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activitySiqing Fu, Aung Naing, Stacy L Moulder, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2018
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvementElena Fountzilas, Elangovan Krishnan, Filip Janku, et al.
Cancer|June 22, 2010
A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Siqing Fu, Chaan Ng, et al.
Pageof 25